SWOG clinical trial number
SWOG-8024

Combined Modality Therapy for Disseminated Soft Tissue Sarcomas

Closed
Phase
Published
Abbreviated Title
Combined Modality Therapy for Disseminated Soft Tissue Sarcomas
Activated
11/25/1980
Closed
06/16/1986

Publication Information Expand/Collapse

1991

A phase III comparison of doxorubicin and DTIC given by bolus vs infusion in patients with soft tissue sarcomas: A Southwest Oncology Group study.

M Zalupski;B Metch;SP Balcerzak;WS Fletcher;R Chapman;JD Bonnet;GR Weiss;J Ryan;R Benjamin;LH Baker JNCI 83:926-932

1987

SWOG-8024: Combined modality therapy for disseminated softtissue sarcoma, phase III.

L Baker;S Green;J Ryan;B Rosenberg;S Balcerzak ASCO :#C-542